Skip to main content
. 2015 Feb;6(1):20–31. doi: 10.1177/2042098614564776

Table 8.

Adverse events after naloxone 2 mg by intramuscular (IM) or intranasal (IN) route [Kerr et al. 2009].

Event term IM (n = 89) IN (n = 83)
n (%) n (%)
‘Minor events’ 17 (19.1%) 16 (19.3%)
 Agitation and/or irritation 7 (7.9%) 5 (6.0%)
 Nausea and/or vomiting 7 (7.9%) 7 (8.4%)
 Headache 3 (3.3%) 4 (4.8%)
‘Major event’
 Convulsion 1 (1.1%) 0 (0%)